These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6449902)

  • 1. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Moody MR; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1980 Aug; 18(2):299-306. PubMed ID: 6449902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
    Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
    J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.
    Schimpff SC; Landesman S; Hahn DM; Standiford HC; Fortner CL; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1976 Nov; 10(5):837-44. PubMed ID: 795372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results.
    Hellriegel KP; Kindler J; Wittenberg C; Kress M
    Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
    Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
    Jones P; Bodey GP; Rolston K; Fainstein V; Riccardi S
    Am J Med; 1988 Jul; 85(1A):3-8. PubMed ID: 3400680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mezlocillin for treatment of infections in cancer patients.
    Issell BF; Bodey GP
    Antimicrob Agents Chemother; 1980 Jun; 17(6):1008-13. PubMed ID: 6447474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of mezlocillin.
    Issell BF; Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1978 Feb; 13(2):180-3. PubMed ID: 646340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
    Finley RS; Fortner CL; deJongh CA; Wade JC; Newman KA; Caplan E; Britten J; Wiernik PH; Schimpff SC
    Antimicrob Agents Chemother; 1982 Aug; 22(2):193-7. PubMed ID: 6765414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
    Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC
    Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
    Gucalp R; Lia S; McKitrick JC; Wiernik PH
    Am J Med; 1988 Jul; 85(1A):31-5. PubMed ID: 3041816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Joshi JH; Newman KA; Brown BW; Finley RS; Ruxer RL; Moody MA; Schimpff SC
    Support Care Cancer; 1993 Jul; 1(4):186-94. PubMed ID: 8193880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mezlocillin in the therapy of serious infections.
    Pancoast SJ; Jahre JA; Neu HC
    Am J Med; 1979 Nov; 67(5):747-52. PubMed ID: 507086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.